Publication Name	World Journal of Gastroenterology
Manuscript ID	16265
Country	South Korea

Received	2015-01-07 08:23
Peer-Review Started	2015-01-07 13:46
First Decision by Editorial Office Director
Return for Revision	2015-05-19 14:45
Revised	2015-06-01 17:27
Publication Fee Transferred
Second Decision by Editor	2015-08-07 17:13
Second Decision by Editor-in-Chief	2015-08-08 00:38
Final Decision by Editorial Office Director	2015-08-31 13:15
Articles in Press	2015-08-31 13:15
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-09-09 17:31
Publish the Manuscript Online	2015-09-28 11:42

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Editorial
Article Title	Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives
Manuscript Source	Invited Manuscript
All Author List	Young Woo Eom, Gaeun Kim and Soon Koo Baik
Funding Agency and Grant Number	Funding Agency Grant Number Yonsei University Future-leading Research Initiative of 2014
Corresponding Author	Soon Koo Baik, MD, PhD, Professor, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital, 20, Ilsanro, Wonju 220-701, South Korea. baiksk@yonsei.ac.kr
Key Words	Cirrhosis; Cell therapy; Bone marrow cells; Mesenchymal stem cells; Hematopoietic stem cells; Immune-modulation; Trophic factors; Anti-fibrosis
Core Tip	Mesenchymal stem cells (MSCs) are considered to be a potential therapeutic agent for the treatment of cirrhosis because of their potential to differentiate into hepatocytes, their immune-modulatory properties and their ability to secrete trophic factors. Nevertheless, several issues, including the fibrogenic potential of MSCs and their ability to promote pre-existing tumor cell growth, must be carefully considered.
Publish Date	2015-09-28 11:42
Citation	Eom YW, Kim G, Baik SK. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives. World J Gastroenterol 2015; 21(36): 10253-10261
URL	http://www.wjgnet.com/1007-9327/full/v21/i36/10253.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i36.10253

Full Article (PDF)	WJG-21-10253.pdf
Full Article (Word)	WJG-21-10253.doc
Manuscript File	16265-Review.docx
Answering Reviewers	16265-Answering reviewers.pdf
Audio Core Tip	16265-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16265-Conflict-of-interest statement.pdf
Copyright License Agreement	16265-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	16265-Language certificate.pdf
Peer-review Report	16265-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16265-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16265-Scientific misconduct check.pdf
Scientific Editor Work List	16265-Scientific editor work list.pdf